FundedIQ
Biotechnology

Prapela: Funding, Investors & Team (Oct 2026)

Prapela is a company dedicated to promoting health and well-being. It surpasses all other companies focused on infant health and wellness around the globe. This accomplishment is a culmination of a decade's worth of hard work in researching and developing SVS products, as well as conducting clinical evaluations with the collaboration of Harvard's Wyss Institute for Biologically Inspired Engineering, the University of Massachusetts Memorial Medical Center, and Massachusetts General Hospital.

prapela.com LinkedIn Biddeford, United States 1-10 employees
Health Care Life Science Wellness Consumer and hospital products Biotechnology Medical device And pediatrics
Total raised
$6.0M
Rounds
2
Latest
Undisclosed round
Mar 2023

Prapela has raised $6.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.5M announced in Mar 2023.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Prapela Company Profile and Key Stats

Total funding raised
$6.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$3.5M in Mar 2023
Employees
1-10
reported band
Headquarters
Biddeford, United States

Latest funding round on record: Mar 2023.

Prapela Funding Rounds

Date
Round
Amount
Undisclosed round
$3.5M
Undisclosed round
$2.5M

Prapela raised $2.5M in an undisclosed round announced in May 2021.

1.8 years later, an undisclosed round of $3.5M was announced in Mar 2023.

Prapela Founders and Leadership Team

Name
Role
Contact
John Konsin
CEO
—

No contact details are on record for this team yet.

Prapela Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Prapela's latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Prapela in Biotechnology and Biddeford

Companies Similar to Prapela

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Prapela Funding FAQs

What does Prapela do?

Prapela is a company dedicated to promoting health and well-being. It surpasses all other companies focused on infant health and wellness around the globe. This accomplishment is a culmination of a decade's worth of hard work in researching and developing SVS products, as well as conducting clinical evaluations with the collaboration of Harvard's Wyss Institute for Biologically Inspired Engineering, the University of Massachusetts Memorial Medical Center, and Massachusetts General Hospital.

How much funding has Prapela raised?

Prapela has raised $6.0M across 2 rounds on record. The most recent is an undisclosed round of $3.5M announced in Mar 2023.

When did Prapela last raise funding?

Prapela's most recent funding round on record is an undisclosed round of $3.5M, announced in Mar 2023.

Who is the CEO of Prapela?

John Konsin is listed as CEO at Prapela.

Where is Prapela headquartered?

Prapela is based in Biddeford, Maine, United States.

How many employees does Prapela have?

Prapela is in the 1-10 employee band.

How does Prapela's funding compare to other Biotechnology startups?

Prapela's latest round of $3.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Prapela Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Prapela is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.